Forouhi N G, Sattar N, Tillin T, McKeigue P M, Chaturvedi N
MRC Epidemiology Unit, Elsie Widdowson Laboratory, Fulbourn Road, Cambridge CB1 9NL, UK.
Diabetologia. 2006 Nov;49(11):2580-8. doi: 10.1007/s00125-006-0393-2. Epub 2006 Sep 14.
AIMS/HYPOTHESIS: We examined prospectively whether measured risk factors can explain the higher CHD mortality in South Asians compared with Europeans.
Conventional CHD risk factors and those associated with insulin resistance were measured in 1,787 European and 1,420 South Asian men aged 40 to 69 years at baseline in the population-based Southall and Brent studies (London) between 1988 and 1990. Participants were followed up for mortality.
By February 2006, there were 202 CHD deaths (108 Asian, 94 European). South Asian men had double the CHD mortality of European men in Cox regression analyses adjusted for age, smoking, and cholesterol (hazard ratio [HR] 2.14, 95% CI 1.56-2.94, p<0.001). Nearly half of all South Asian CHD deaths versus 13% of deaths among Europeans were among persons with diabetes. Asian men had greater CHD mortality than Europeans, both in the with- and the without-diabetes categories at baseline. CHD mortality remained significantly higher in South Asian men in multivariable models that adjusted for conventional risk factors and diabetes and/or impaired glucose regulation, features of insulin resistance, or the metabolic syndrome (HR 1.6-1.9). Accounting for co-morbidity and socio-economic status did not materially alter the findings.
CONCLUSIONS/INTERPRETATION: These data confirm that South Asian men have significantly higher CHD mortality than their European counterparts, while indicating that neither conventional risk factors, nor insulin resistance parameters or metabolic syndrome criteria as currently defined can account for this excess risk. The contribution of unmeasured factors to the elevated vascular risk in South Asians should be addressed in future studies.
目的/假设:我们前瞻性地研究了所测量的风险因素是否能够解释南亚人相较于欧洲人更高的冠心病死亡率。
在基于人群的索撒尔和布伦特研究(伦敦)中,于1988年至1990年对1787名40至69岁的欧洲男性和1420名南亚男性进行了基线常规冠心病风险因素以及与胰岛素抵抗相关因素的测量。对参与者进行死亡率随访。
至2006年2月,有202例冠心病死亡(108例亚洲人,94例欧洲人)。在针对年龄、吸烟和胆固醇进行校正的Cox回归分析中,南亚男性的冠心病死亡率是欧洲男性的两倍(风险比[HR] 2.14,95%置信区间1.56 - 2.94,p<0.001)。所有南亚冠心病死亡病例中近一半患有糖尿病,而欧洲死亡病例中这一比例为13%。在基线时,无论有无糖尿病,亚洲男性的冠心病死亡率均高于欧洲男性。在对常规风险因素、糖尿病和/或血糖调节受损、胰岛素抵抗特征或代谢综合征进行校正的多变量模型中,南亚男性的冠心病死亡率仍然显著更高(HR 1.6 - 1.9)。考虑合并症和社会经济状况并未实质性改变研究结果。
结论/解读:这些数据证实,南亚男性的冠心病死亡率显著高于欧洲男性,同时表明目前所定义的常规风险因素、胰岛素抵抗参数或代谢综合征标准均无法解释这种额外风险。未来的研究应探讨未测量因素对南亚人血管风险升高的影响。